Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位基因排除机制和功能
基本信息
- 批准号:10020899
- 负责人:
- 金额:$ 44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-19 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AllelesAntigen ReceptorsAutoimmune DiabetesAutoimmunityB-LymphocytesBindingBiochemicalBiological AssayCellsComplexDNA Double Strand BreakDataDevelopmentDiseaseEnsureExclusionExhibitsFeedbackFrequenciesGenesGeneticGenetic RecombinationGenetic TranscriptionHomeostasisIgKImmuneImmunologyIn VitroInbred NOD MiceIncidenceInvestigationKnowledgeLymphocyteLymphomaMediatingModelingMolecularMusOncogenicPathologyPeptide Signal SequencesPhysiologicalPredispositionProcessReceptor GeneRoleS PhaseSignal TransductionSpecificityT-Cell DevelopmentT-LymphocyteTestingTimeTransgenic OrganismsV(D)J RecombinationWorkautoreactivitybaseendonucleasein vivomouse modelreceptorreceptor expressionresponsetheoriesthymocyte
项目摘要
ABSTRACT
Most T and B cells exhibit mono-allelic expression (allelic exclusion) of antigen receptor (AgR) genes. Although
allelic exclusion was discovered in 1965, its underlying mechanisms and role(s) remain elusive. The initial and
prevailing model for allelic exclusion is that expression of one type (specificity) of AgR inhibits autoimmunity by
ensuring negative selection of cells with a self-reactive AgR. Consistent with this view, the expression of a second
non-autoreactive AgR enables cells expressing a transgenic autoreactive AgR to evade negative selection. Yet,
there remains a knowledge gap regarding effects of bi-allelic expression of endogenous TCRb, IgH, or Igk genes
whose stringent allelic exclusion is achieved by mono-allelic initiation and feedback inhibition of V recombination.
In addition to the likely benefit of mono-allelic expression, the applicant theorizes that mono-allelic AgR assembly
suppresses oncogenic translocations from RAG endonuclease-generated DNA double strand breaks (DSBs).
An obstacle to elucidating roles of allelic exclusion is the lack of a proven mechanism for mono-allelic initiation
of V recombination. This has precluded experimental approaches to increase bi-allelic assembly and expression
of AgR loci without otherwise altering V(D)J recombination, DSB responses, and/or lymphocyte development.
Recombination signal sequences (RSSs) mediate V(D)J recombination by directing RAG activity. The applicant
shows mice harboring replacement of Vb RSSs with a stronger RSS have substantially increased development
of T cells with bi-allelic TCRb expression due to increased bi-allelic Vb recombination. Based on his preliminary
data, the applicant hypothesizes that weak Vb and VH RSSs limit V recombination to restrict the incidence of V
rearrangements on both alleles before feedback inhibition halts further V recombination. He hypothesizes that
this stochastic mechanism of lowering V recombination frequency can be exploited to test roles of mono-allelic
assembly and expression of TCRb, and possibly IgH, in immune homeostasis. He proposes two complementary
but independent aims to test key aspects of these hypotheses. In Aim 1, the PI will use complementary in vitro
biochemical and in vivo molecular assays to determine unequivocally whether inherently weak Vb and VH RSSs
limit V recombination to enforce mono-allelic initiation of V recombination. In Aim 2, he will use Vb and VH RSS
replacement mice to determine the impact of increasing bi-allelic assembly and expression of TCRb or IgH on
negative selection of self-reactive cells, predisposition to autoimmunity, and genesis of oncogenic translocations.
This project will show how RSSs control mono-allelic assembly and expression of TCRb, and identify if the same
stochastic mechanism enforces IgH allelic exclusion. The data will, for the first time, demonstrate a mechanism
for mono-allelic initiation of V recombination. The study has great potential to provide definitive evidence for a
fundamental tenet of immunology proposed in 1965, but that remains unproven today. The work also may reveal
an additional important benefit of mono-allelic initiation of V rearrangements in suppressing lymphoma.
抽象的
大多数T和B细胞表现出抗原受体(AGR)基因的单相关表达(等位基因排除)。虽然
1965年发现了等位基因排除,其基本机制和角色仍然难以捉摸。最初和
等位基因排除的流行模型是,AGR的一种类型(特异性)的表达抑制自身免疫性
确保用自反应性AGR进行负面选择。与这种观点一致,一秒钟的表达
非AutoreActive AGR使表达转基因自动反应性AGR的细胞能够逃避负面选择。然而,
关于内源性TCRB,IGH或IGK基因的双重平行表达的影响的知识差距仍然存在差距
通过单相关的启动和V重组的反馈抑制,其严格的等位基因排除是实现的。
除了单相表达的可能益处外,申请人还理论上了单相关AGR组装
抑制抹布核酸内切酶产生的DNA双链断裂(DSB)的致癌易位。
阐明等位基因排除作用的障碍是缺乏可靠的单相关启动机制
V重组。这排除了实验方法,以增加双行组装和表达
AGR基因座的of而没有其他改变V(d)J重组,DSB反应和/或淋巴细胞发育。
重组信号序列(RSS)通过指导抹布活性介导V(d)J重组。申请人
显示具有更强RSS的VB RSS替代的小鼠已经大大增加了发育
由于BI-calilleic VB重组的增加而导致具有BI-平行性TCRB表达的T细胞的T细胞。根据他的初步
数据,申请人假设弱VB和VH RSS限制了V重组以限制V的发生率
反馈抑制之前,两个等位基因上的重排停止了V重组。他假设这一点
可以利用这种降低V重组频率的随机机制来测试单相关的角色
免疫稳态中TCRB的组装和表达,甚至可能是IGH。他提出了两个补充
但是独立旨在检验这些假设的关键方面。在AIM 1中,PI将使用互补的体外
生化和体内分子测定,以明确确定固有的弱VB和VH RSSSS是否存在
限制V重组以实施V重组的单相关启动。在AIM 2中,他将使用VB和VH RSS
替换小鼠以确定增加双性组装和TCRB或IGH表达的影响
自我反应性细胞的负选择,自身免疫性的倾向以及致癌易位的起源。
该项目将显示RSS如何控制TCRB的单相关组件和表达,并确定是否相同
随机机制执行IGH等位基因排除。数据将首次演示一种机制
用于V重组的单相关开始。该研究具有很大的潜力,可以为
1965年提出的免疫学的基本原则,但今天仍未得到证实。这项工作也可能揭示
抑制淋巴瘤中V重排的单相关开始的另一个重要优势。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG H BASSING其他文献
CRAIG H BASSING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG H BASSING', 18)}}的其他基金
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10538891 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Exploring a Functional Role of Chromosome Loop Extrusion Direction on Regulating Genome Biology
探索染色体环挤出方向在调节基因组生物学中的功能作用
- 批准号:
10606672 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10664014 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位排除机制和功能
- 批准号:
10684807 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位排除机制和功能
- 批准号:
10231184 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位基因排除机制和功能
- 批准号:
10466824 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位排除机制和功能
- 批准号:
9917182 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
淋巴细胞发育过程中抗原受体位点的拓扑控制
- 批准号:
10238038 - 财政年份:2017
- 资助金额:
$ 44万 - 项目类别:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
淋巴细胞发育过程中抗原受体位点的拓扑控制
- 批准号:
9753111 - 财政年份:2017
- 资助金额:
$ 44万 - 项目类别:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
淋巴细胞发育过程中抗原受体位点的拓扑控制
- 批准号:
9447778 - 财政年份:2017
- 资助金额:
$ 44万 - 项目类别:
相似国自然基金
嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
- 批准号:52375565
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
体内构建嵌合抗原受体Kupffer细胞(CAR-KC)并借助“细胞变装”策略实现肝癌双靶杀伤
- 批准号:82304398
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双靶向CSPG4/CD126嵌合抗原受体修饰的复制缺失型弓形虫减毒活疫苗(CAR-Tg)抗恶性黑色素瘤的效应及机制研究
- 批准号:32370997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向c-MET以及CD133的串联双靶点嵌合抗原受体—巨噬细胞(CAR-M)对胰腺癌的杀伤及化疗协同增效作用及机制研究
- 批准号:82373230
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10178141 - 财政年份:2020
- 资助金额:
$ 44万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10055413 - 财政年份:2020
- 资助金额:
$ 44万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10431828 - 财政年份:2020
- 资助金额:
$ 44万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10647749 - 财政年份:2020
- 资助金额:
$ 44万 - 项目类别: